Search results for "breast"

showing 10 items of 1871 documents

Targeting Orthosteric and Allosteric Pockets of Aromatase via Dual-Mode Novel Azole Inhibitors

2020

[Image: see text] Breast cancer (BC) is the most diffused cancer type in women and the second leading cause of death among the female population. Effective strategies to fight estrogen responsive (ER+) BC, which represents 70% of all BC cases, rely on estrogen deprivation, via the inhibition of the aromatase enzyme, or the modulation of its cognate estrogen receptor. Current clinical therapies significantly increased patient survival time. Nevertheless, the onset of resistance in metastatic BC patients undergoing prolonged treatments is becoming a current clinical challenge, urgently demanding to devise innovative strategies. In this context, here we designed, synthesized, and performed in …

medicine.drug_classAllosteric regulation01 natural sciencesBiochemistryBreast cancerbreast cancerDrug Discoverymedicinecytochromes P450AromataseCause of deathFemale populationchemistry.chemical_classificationbiology010405 organic chemistrybusiness.industrymolecular dynamicOrganic ChemistryDual modeAromatase inhibitormedicine.diseasemolecular dynamics0104 chemical sciences010404 medicinal & biomolecular chemistryAromatase inhibitorschemistryEstrogenSettore CHIM/03 - Chimica Generale E Inorganicaxanthonebiology.proteinCancer researchAzolebusiness
researchProduct

Cytotoxic effects of Jay Amin hydroxamic acid (JAHA), a ferrocene-based class I histone deacetylase inhibitor, on triple-negative MDA-MB231 breast ca…

2012

The histone deacetylase inhibitors (HDACis) are a class of chemically heterogeneous anticancer agents of which suberoylanilide hydroxamic acid (SAHA) is a prototypical member. SAHA derivatives may be obtained by three-dimensional manipulation of SAHA aryl cap, such as the incorporation of a ferrocene unit like that present in Jay Amin hydroxamic acid (JAHA) and homo-JAHA [ Spencer , et al. ( 2011 ) ACS Med. Chem. Lett. 2 , 358 - 362 ]. These metal-based SAHA analogues have been tested for their cytotoxic activity toward triple-negative MDA-MB231 breast cancer cells. The results obtained indicate that of the two compounds tested, only JAHA was prominently active on breast cancer cells with a…

medicine.drug_classCell SurvivalMetallocenesAntineoplastic AgentsApoptosisToxicologyHydroxamic AcidsStructure-Activity RelationshipIn vivoAnnexinmedicineTumor Cells CulturedCytotoxic T cellHumansFerrous CompoundsSettore BIO/06 - Anatomia Comparata E Citologiachemistry.chemical_classificationMembrane Potential MitochondrialReactive oxygen speciesDose-Response Relationship DrugMolecular StructureChemistryHistone deacetylase inhibitorCell CycleGeneral MedicineIn vitroHistone Deacetylase InhibitorsBiochemistryhistone deacetylase inhibitor breast cancer autophagy apoptosis mitochondria cell cycleApoptosisCancer researchHistone deacetylaseDrug Screening Assays AntitumorReactive Oxygen Species
researchProduct

Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer

2019

There is still a great unmet medical need concerning diagnosis and treatment of breast cancer which could be addressed by utilizing specific molecular targets. Tumor-associated MUC1 is expressed on over 90 % of all breast cancer entities and differs strongly from its physiological form on epithelial cells, therefore presenting a unique target for breast cancer diagnosis and antibody-mediated immune therapy. Utilizing an anti-tumor vaccine based on a synthetically prepared glycopeptide, we generated a monoclonal antibody (mAb) GGSK-1/30, selectively recognizing human tumor-associated MUC1. This antibody targets exclusively tumor-associated MUC1 in the absence of any binding to MUC1 on health…

medicine.drug_classEstrogen receptorMUC1Breast NeoplasmsMice TransgenicDeferoxamineMonoclonal antibody89Zr03 medical and health sciences0302 clinical medicineBreast cancerIn vivoCell Line TumorBiomarkers TumormedicineAnimalsHumansTissue Distributionskin and connective tissue diseasesMUC1Triple-negative breast cancermAbRadioisotopesMice Inbred BALB Cbiologybusiness.industryMucin-1breast cancer diagnosisAntibodies MonoclonalCancerGeneral MedicinePrognosismedicine.diseaseImmunohistochemistryMice Inbred C57BLPositron-Emission Tomographybiology.proteinCancer researchFemale030211 gastroenterology & hepatologyZirconiumAntibodybusinessResearch PaperInternational Journal of Medical Sciences
researchProduct

(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.

2015

Breast cancer remains the leading cause of cancer-related death among women. The invasive triple-negative subtype is unresponsive to estrogen therapy, and few effective treatments are available. In search of new chemical scaffolds to target this disease, we conducted a phenotypic screen against the human breast carcinoma cell lines MDA-MB-231, MA11, and MCF-7 using terrestrial natural products. Natural products that preferentially inhibited proliferation of triple-negative MDA-MB-231 cells over estrogen receptor-positive cells were further studied; herein we focused on the abietanes. The activity of the abietane carnosol prompted us to generate a focus library from the readily available (+)…

medicine.drug_classPhenotypic screeningApoptosisTriple Negative Breast NeoplasmsPharmacologyCarnosolchemistry.chemical_compoundStructure-Activity RelationshipBreast cancerCell Line TumorDrug DiscoverymedicineHumansTriple-negative breast cancerCell ProliferationPharmacologyBiological ProductsDose-Response Relationship DrugMolecular StructureCell growthDrug discoveryOrganic ChemistryStereoisomerismGeneral MedicineTriple Negative Breast Neoplasmsmedicine.diseaseAntineoplastic Agents PhytogenicchemistryEstrogenAbietanesMCF-7 CellsFemaleDrug Screening Assays AntitumorEuropean journal of medicinal chemistry
researchProduct

Structural, Thermodynamic, and Kinetic Traits of Antiestrogen-Compounds Selectively Targeting the Y537S Mutant Estrogen Receptor α Transcriptional Ac…

2019

The most frequently diagnosed cancers in women are the estrogen receptor (ER)-positive breast cancer subtypes, which are characterized by estrogen dependency for their growth. The mainstay of clinical treatment for this tumor relies on the modulation of ER action or on the suppression of estrogen biosynthesis via the administration of Selective ERα Modulators/Down-regulators (SERMs/SERDs) or aromatase inhibitors, respectively. Nevertheless, de novo and acquired resistance to these therapies frequently occurs and represents a major clinical concern for patient survival. Recently, somatic mutations affecting the hormone-binding domain of ERα (i. e. Y537S, Y537N, D538G) have been associated w…

medicine.drug_classSomatic cellIn silicoEstrogen receptor-02 engineering and technology010402 general chemistry01 natural scienceslcsh:ChemistryBreast cancerbreast cancermedicineAromataseresistant breast cancersOriginal ResearchbiologyChemistryWild typeY537SGeneral Chemistry021001 nanoscience & nanotechnologyAntiestrogenmedicine.diseaseSERMmolecular dynamics0104 chemical sciencesChemistrylcsh:QD1-999EstrogenSERDbiology.proteinCancer research0210 nano-technologyestrogen receptorFrontiers in chemistry
researchProduct

A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables th…

2015

In studies within the realm of cancer immunotherapy, the synthesis of exactly specified tumor-associated glycopeptide antigens is shown to be a key strategy for obtaining a highly selective biological reagent, that is, a monoclonal antibody that completely differentiates between tumor and normal epithelial cells and specifically marks the tumor cells in pancreas tumors. Mucin MUC1, which is overexpressed in many prevalent cancers, was identified as a promising target for this strategy. Tumor-associated MUC1 differs significantly from that expressed by normal cells, in particular by altered glycosylation. Structurally defined tumor-associated MUC1 cannot be isolated from tumor cells. We synt…

medicine.drug_classmedicine.medical_treatmentTumor M2-PKBreast NeoplasmsBiology010402 general chemistryMonoclonal antibody01 natural sciencesCancer VaccinesCatalysisCancer immunotherapyAntigenPancreatic tumorPancreatic cancermedicineHumansBreastMUC1010405 organic chemistryMucinGlycopeptidesAntibodies MonoclonalGeneral Chemistrymedicine.diseaseMolecular biology0104 chemical sciencesPancreatic NeoplasmsFemaleAngewandte Chemie (International ed. in English)
researchProduct

Modern Aspects in the Diagnosis and Surgical Treatment of Breast Cancer in Early Stages

2021

Abstract Breast cancer is the most common cancer in women and a major public health problem, affecting 2.1 million women each year globally and causing the highest number of cancer-related deaths among women. In 2018, an estimated 627,000 women died from breast cancer (about 15% of all cancer deaths among women). To improve survival, early detection is essential. There are two strategies for early detection of breast cancer: early diagnosis and screening.(1) In Romania, the latest statistics show a higher incidence of breast cancer compared to the European average of 7929 new cases / year with a mortality of 3101 deaths / year.(2)

medicine.medical_specialty030219 obstetrics & reproductive medicinebusiness.industryObstetricsIncidence (epidemiology)Public healthEarly detectionCancerGeneral Medicinemedicine.disease03 medical and health sciences0302 clinical medicineBreast cancer030220 oncology & carcinogenesisMedicinebusinessSurgical treatmentActa Medica Transilvanica
researchProduct

Standard and Specialized Infant Formulas in Europe: Making, Marketing, and Health Outcomes

2019

Infant formulas are the only suitable substitute for human milk. The most common infant formulas are standard formulas based on cow's milk. In addition, there are formulas for infants showing signs and symptoms of intolerance and for clinical conditions such as allergy, prematurity, and gastrointestinal diseases. A comprehensive review of the literature was made to review the composition of standard and specialized infant formulas and analyze indications for use, real or presumed nutrition differences and properties, and impact on infant growth. A brief consideration on costs is outlined for each formula. Over the past few years, industrial production and advertising of infant formulas have…

medicine.medical_specialty030309 nutrition & dieteticsBreastfeedingMedicine (miscellaneous)Signs and symptomsHealth outcomes03 medical and health sciences0302 clinical medicineOutcome Assessment Health CaremedicineAnimalsHumansenteral nutritionIntensive care medicineInfant Nutritional Physiological PhenomenaFood FormulatedMarketing0303 health sciencesNutrition and DieteticsMilk Humaninfant nutritionbusiness.industryInfant Newbornhuman milkInfant nutritioninfant formulaNutrientsinfantEuropeParenteral nutritionBreast FeedingMilkInfant formula030211 gastroenterology & hepatologyenteral nutrition; human milk; infant; infant formula; infant nutritionbusiness
researchProduct

Diagnostic challenges and potential early indicators of breast periprosthetic anaplastic large cell lymphoma

2020

Abstract Rationale: Anaplastic large T-cell lymphoma (BI-ALCL) is a rare primitive lymphoma described in women with breast implant prostheses, which has been arousing interest in recent years due to its potentially high social impact. The difficult diagnosis associated with the high and increasing number of prosthetic implants worldwide has led to hypothesize an underestimation of the real impact of the disease among prosthesis-bearing women. The aim of this work is to search for specific radiological signs of disease linked to the chronic inflammatory pathogenetic mechanism. Patient concerns: This work describes a case of BI-ALCL in an American woman with no personal or family history of c…

medicine.medical_specialty5700Axillary lymph nodesBreast ImplantsPeriprostheticbreast magnetic resonancelaw.inventionDiagnosis Differential03 medical and health sciences0302 clinical medicinelawmedicineMammographyHumans030212 general & internal medicineClinical Case ReportAnaplastic large-cell lymphomaBreast augmentationmedicine.diagnostic_testperiprosthetic anaplastic lymphomabusiness.industryBiopsy NeedleGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistryMagnetic Resonance Imagingmedicine.anatomical_structureSeromaanaplastic large cell lymphoma030220 oncology & carcinogenesisSeromaBreast implantLymphoma Large-Cell AnaplasticFemaleRadiologyUltrasonography MammaryDifferential diagnosisbusinessbreast implantHumanMammographyResearch ArticleMedicine
researchProduct

Postoperative education concerning the use of the upper limb, and exercise and treatment of the upper limb: cross-sectional survey of 105 breast canc…

2003

In this retrospective survey we investigated the recall of breast cancer patients (n=105) 6 months after the operation concerning postoperative instructions on exercises for shoulder mobility, and instructions for oedema prevention and treatment, upper limb strength training and the use of the upper limb in daily activities. Patients also described the content in their own words and ranked the instructors who had mostly given this education. Operation type and length of hospital stay did not have any effect on the education recalled, but the age of the respondent had some effect (r=−0.23, p<0.05). The Wilcoxon signed ranks test showed that the most commonly reported item was instructions on…

medicine.medical_specialtyActivities of daily livingCross-sectional studyStrength trainingmedicine.medical_treatmentBreast NeoplasmsPhysiotherapy assistant03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationBreast cancerPatient Education as TopicMedicineEdemaHumansExerciseFinlandRehabilitation030504 nursingbusiness.industrymedicine.disease3. Good healthmedicine.anatomical_structureCross-Sectional StudiesOncology030220 oncology & carcinogenesisRespondentPhysical therapyArmUpper limbFemale0305 other medical sciencebusinessSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
researchProduct